In vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release

Janos Zempleni, R. M. Helm, D. M. Mock

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Theoretically, vitamin supplements may either enhance or reduce protein synthesis and proliferation in peripheral blood mononuclear cells (PBMC). In the present study, we determined whether administration of a pharmacologic dose of biotin affects proliferation rates of PBMC and cytokine release. Healthy adults (n = 5) ingested 3.1 μmol biotin/d for 14 d; blood and urine were collected pre- and postsupplementation. PBMC were isolated by density gradient and incubated with the mitogen concanavalin A for up to 3 d. At timed intervals during mitogen stimulation, we measured the following: 1) cellular uptake of [3H]thymidine to determine proliferation rates; 2) concentrations of various cytokines released into the medium; and 3) the percentages of PBMC subsets as judged by CD surface markers. Biotin supplementation caused a significant decrease of PBMC proliferation. At 2 d after mitogen stimulation, [3H]thymidine uptake by postsupplementation PBMC was 66 ± 21% of the uptake by presupplementation PBMC (P < 0.05). Similarly, concentrations of interleukin-1β (2 d after mitogen) and interleukin-2 (1 d after mitogen) in media from postsupplementation PBMC were 65 ± 28% and 44 ± 23%, respectively, of those for presupplementation PBMC (P < 0.01). Percentages of PBMC subsets were not affected by 14 d of biotin supplementation. Overall, this study provides evidence that administration of pharmacologic doses of biotin for 14 d decreases PBMC proliferation and synthesis of interleukin-1β and interleukin-2.

Original languageEnglish (US)
Pages (from-to)1479-1484
Number of pages6
JournalJournal of Nutrition
Volume131
Issue number5
StatePublished - May 21 2001

Fingerprint

biotin
Biotin
mononuclear leukocytes
Blood Cells
cytokines
Cytokines
dosage
Mitogens
Interleukin-1
Interleukin-2
interleukin-1
thymidine
interleukin-2
uptake mechanisms
Thymidine
cell proliferation
Cell Proliferation
vitamin supplements
concanavalin A
Concanavalin A

Keywords

  • Biotin
  • Cytokines
  • Humans
  • Lymphocytes
  • Proliferation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

In vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release. / Zempleni, Janos; Helm, R. M.; Mock, D. M.

In: Journal of Nutrition, Vol. 131, No. 5, 21.05.2001, p. 1479-1484.

Research output: Contribution to journalArticle

@article{d745003256104b0f83f0b2cea5ea7d74,
title = "In vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release",
abstract = "Theoretically, vitamin supplements may either enhance or reduce protein synthesis and proliferation in peripheral blood mononuclear cells (PBMC). In the present study, we determined whether administration of a pharmacologic dose of biotin affects proliferation rates of PBMC and cytokine release. Healthy adults (n = 5) ingested 3.1 μmol biotin/d for 14 d; blood and urine were collected pre- and postsupplementation. PBMC were isolated by density gradient and incubated with the mitogen concanavalin A for up to 3 d. At timed intervals during mitogen stimulation, we measured the following: 1) cellular uptake of [3H]thymidine to determine proliferation rates; 2) concentrations of various cytokines released into the medium; and 3) the percentages of PBMC subsets as judged by CD surface markers. Biotin supplementation caused a significant decrease of PBMC proliferation. At 2 d after mitogen stimulation, [3H]thymidine uptake by postsupplementation PBMC was 66 ± 21{\%} of the uptake by presupplementation PBMC (P < 0.05). Similarly, concentrations of interleukin-1β (2 d after mitogen) and interleukin-2 (1 d after mitogen) in media from postsupplementation PBMC were 65 ± 28{\%} and 44 ± 23{\%}, respectively, of those for presupplementation PBMC (P < 0.01). Percentages of PBMC subsets were not affected by 14 d of biotin supplementation. Overall, this study provides evidence that administration of pharmacologic doses of biotin for 14 d decreases PBMC proliferation and synthesis of interleukin-1β and interleukin-2.",
keywords = "Biotin, Cytokines, Humans, Lymphocytes, Proliferation",
author = "Janos Zempleni and Helm, {R. M.} and Mock, {D. M.}",
year = "2001",
month = "5",
day = "21",
language = "English (US)",
volume = "131",
pages = "1479--1484",
journal = "The Journal of nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "5",

}

TY - JOUR

T1 - In vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release

AU - Zempleni, Janos

AU - Helm, R. M.

AU - Mock, D. M.

PY - 2001/5/21

Y1 - 2001/5/21

N2 - Theoretically, vitamin supplements may either enhance or reduce protein synthesis and proliferation in peripheral blood mononuclear cells (PBMC). In the present study, we determined whether administration of a pharmacologic dose of biotin affects proliferation rates of PBMC and cytokine release. Healthy adults (n = 5) ingested 3.1 μmol biotin/d for 14 d; blood and urine were collected pre- and postsupplementation. PBMC were isolated by density gradient and incubated with the mitogen concanavalin A for up to 3 d. At timed intervals during mitogen stimulation, we measured the following: 1) cellular uptake of [3H]thymidine to determine proliferation rates; 2) concentrations of various cytokines released into the medium; and 3) the percentages of PBMC subsets as judged by CD surface markers. Biotin supplementation caused a significant decrease of PBMC proliferation. At 2 d after mitogen stimulation, [3H]thymidine uptake by postsupplementation PBMC was 66 ± 21% of the uptake by presupplementation PBMC (P < 0.05). Similarly, concentrations of interleukin-1β (2 d after mitogen) and interleukin-2 (1 d after mitogen) in media from postsupplementation PBMC were 65 ± 28% and 44 ± 23%, respectively, of those for presupplementation PBMC (P < 0.01). Percentages of PBMC subsets were not affected by 14 d of biotin supplementation. Overall, this study provides evidence that administration of pharmacologic doses of biotin for 14 d decreases PBMC proliferation and synthesis of interleukin-1β and interleukin-2.

AB - Theoretically, vitamin supplements may either enhance or reduce protein synthesis and proliferation in peripheral blood mononuclear cells (PBMC). In the present study, we determined whether administration of a pharmacologic dose of biotin affects proliferation rates of PBMC and cytokine release. Healthy adults (n = 5) ingested 3.1 μmol biotin/d for 14 d; blood and urine were collected pre- and postsupplementation. PBMC were isolated by density gradient and incubated with the mitogen concanavalin A for up to 3 d. At timed intervals during mitogen stimulation, we measured the following: 1) cellular uptake of [3H]thymidine to determine proliferation rates; 2) concentrations of various cytokines released into the medium; and 3) the percentages of PBMC subsets as judged by CD surface markers. Biotin supplementation caused a significant decrease of PBMC proliferation. At 2 d after mitogen stimulation, [3H]thymidine uptake by postsupplementation PBMC was 66 ± 21% of the uptake by presupplementation PBMC (P < 0.05). Similarly, concentrations of interleukin-1β (2 d after mitogen) and interleukin-2 (1 d after mitogen) in media from postsupplementation PBMC were 65 ± 28% and 44 ± 23%, respectively, of those for presupplementation PBMC (P < 0.01). Percentages of PBMC subsets were not affected by 14 d of biotin supplementation. Overall, this study provides evidence that administration of pharmacologic doses of biotin for 14 d decreases PBMC proliferation and synthesis of interleukin-1β and interleukin-2.

KW - Biotin

KW - Cytokines

KW - Humans

KW - Lymphocytes

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=0035013946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035013946&partnerID=8YFLogxK

M3 - Article

VL - 131

SP - 1479

EP - 1484

JO - The Journal of nutrition

JF - The Journal of nutrition

SN - 0022-3166

IS - 5

ER -